Enomoto, Takatoshi
Takeda, Yoshito
Shirai, Yuya
Hasegawa, Takehiro
Zhao, Feng
Lunding, Hanna
Pohl, Moritz
Edahiro, Ryuya
Shichino, Shigeyuki
Kawasaki, Takahiro
Yoshimura, Hanako
Hara, Reina
Amiya, Saori
Yamamoto, Makoto
Nakatsubo, Daisuke
Tanizaki, Satoshi
Nakayama, Mana
Noda, Yoshimi
Niitsu, Takayuki
Adachi, Yuichi
Tone, Mari
Abe, Yuko
Naito, Maiko
Masuhiro, Kentaro
Naito, Yujiro
Shiroyama, Takayuki
Miyake, Kotaro
Koyama, Shohei
Fukushima, Kiyoharu
Iwahori, Kota
Hirata, Haruhiko
Nagatomo, Izumi
Nojima, Satoshi
Yanagawa, Masahiro
Inoue, Yoshikazu
Kumanogoh, Atsushi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP19K08650, Grant-in-Aid for Transformative Research Areas (B) 22H05064, JP18H05282)
Uehara Memorial Foundation grant
Japanese Respiratory Foundation grant
Japan Agency for Medical Research and Development (JP21gm6210025, JP223fa627002)
Article History
Received: 23 August 2024
Accepted: 14 April 2025
First Online: 23 April 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki for medical research involving human participants and was approved by the Osaka University Hospital Ethics Committee (approval number: 17148). All animal experiments were reviewed and approved by the Animal Experiment Committee of Osaka University (approval number: 01-021-016). Written informed consent was obtained from all patients before enrollment in this study.
: Not applicable.
: Y.I. received honoraria from Boehringer Ingelheim, Roche, GlaxoSmithKline, Taiho, Shionogi, Savara, and Kyorin. T.H., F.Z., and H.L. are employees of Sysmex R&D Center Europe GmbH. M.P. is an employee of Oxford Gene Technology.